Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion type Assertion NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_head.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion wasGeneratedBy ECO_0000203 NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_provenance.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion wasDerivedFrom befree-20150227 NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_provenance.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion SIO_000772 16778195 NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_provenance.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion evidence source_evidence_literature NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_provenance.
- NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_assertion description "[The incidence of ASC/TMS1 hypermethylation in sputum DNA fully mimics the tissue findings being present in only 2% (2 of 85) of high-risk, cancer-free smokers, 15% (3 of 18) of patients with stage I non-small-cell lung cancer (NSCLC), but 41% of patients with stage III NSCLC (18 of 44), including 56% (10 of 18) of those with adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252912.RAn3wm-hMY82y3PUocN7PiK0sgrEXwgnLgsBda0E4Ei7M130_provenance.